E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
Times Cited: 35
Times Cited: 35
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
Times Cited: 117
Times Cited: 117
List of shared articles
Times cited
α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport.
Nadeeja Wijesekara, Rosemary Ahrens, Ling Wu, Tammy Langman, Anurag Tandon, Paul E Fraser. Front Aging Neurosci 2021
Nadeeja Wijesekara, Rosemary Ahrens, Ling Wu, Tammy Langman, Anurag Tandon, Paul E Fraser. Front Aging Neurosci 2021
Association between diabetes mellitus and risk of Parkinson's disease: A prisma-compliant meta-analysis.
Wei Liu, Jianfeng Tang. Brain Behav 2021
Wei Liu, Jianfeng Tang. Brain Behav 2021
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
Diabetic retinopathy as a potential marker of Parkinson's disease: a register-based cohort study.
Maria E C Larsen, Anne S Thykjaer, Frederik N Pedersen, Sören Möller, Caroline S Laugesen, Nis Andersen, Jens Andresen, Javad Hajari, Steffen Heegaard, Kurt Højlund,[...]. Brain Commun 2021
Maria E C Larsen, Anne S Thykjaer, Frederik N Pedersen, Sören Möller, Caroline S Laugesen, Nis Andersen, Jens Andresen, Javad Hajari, Steffen Heegaard, Kurt Højlund,[...]. Brain Commun 2021
Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.
Dilan Athauda, Thomas Foltynie. Neuropharmacology 2018
Dilan Athauda, Thomas Foltynie. Neuropharmacology 2018
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study.
H S Chung, J S Lee, J A Kim, E Roh, Y-B Lee, S-H Hong, J H Yu, N H Kim, H J Yoo, J A Seo,[...]. Diabetes Metab 2021
H S Chung, J S Lee, J A Kim, E Roh, Y-B Lee, S-H Hong, J H Yu, N H Kim, H J Yoo, J A Seo,[...]. Diabetes Metab 2021